mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.8 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.8 |